Fisher E R, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L
Cancer. 1986 May 1;57(9):1717-24. doi: 10.1002/1097-0142(19860501)57:9<1717::aid-cncr2820570902>3.0.co;2-h.
One hundred ten local breast recurrences were observed in 1108 pathologically evaluable patients enrolled in NSABP protocol 6 who were treated by lumpectomy and followed for 5 to 95 months (average, 39 months). Eighty-six percent and 95% of all local breast recurrences were noted within 4 and 5 years, respectively, following lumpectomy. Life table analysis revealed their incidence to be 24% for those not and 6% for those receiving lumpectomy and breast irradiation. One hundred four (95%) of the breast recurrences involved the mammary parenchyma and the remaining 6 (5%) involved the skin and/or nipple only. Eleven (10%) of the former were noninvasive. The most common (86%) presentation of breast recurrence appeared to be a localized mass within or close to the quadrant of the index cancer. In 14% the recurrence not only involved the same quadrant, but was more diffuse within the breast extending to remote areas as well. This type was characterized pathologically by marked intralymphatic extension as well as involvement of the overlying skin and/or nipple after the fashion of so-called inflammatory or occult inflammatory breast cancer. The recurrences noted in the skin and/or nipple only were also pathologically characterized by intralymphatic involvement at these sites in the majority of instances. These two forms of breast recurrences appear to reflect the localized growth of highly aggressive invasive breast cancers. The concordance of histologic types and grades of the index and recurrent cancers implies that such events represent growth of overlooked tumor, a deficiency attendant with lumpectomy due to the extreme multifocal nature (not multicentricity) of some breast cancers and/or inadequacies in evaluating the lines of resection of lumpectomy specimens. Sources of error in regard to this latter are identified and guidelines for the examination of such specimens, as well as the assessment of margins, are presented. The observation that local breast recurrences noted following lumpectomy occurred within or close to the same quadrant as the index cancer, despite the presence of multicentric noninvasive cancers in 10% of the patients treated by total mastectomy, minimizes the biological and clinical significance of multicentric foci of cancer present in some breast cancers. Cancer measuring greater than or equal to 2.0 cm, having high histologic and nuclear grades, or intralymphatic extension, were found to have a statistically significant association with local breast recurrence in all patients following lumpectomy. A converse relationship was noted with tubular and scar cancers of types 1 and 4.(ABSTRACT TRUNCATED AT 400 WORDS)
在参加NSABP方案6的1108例接受病理评估的患者中观察到110例局部乳腺复发,这些患者接受了肿块切除术,并随访5至95个月(平均39个月)。所有局部乳腺复发中,分别有86%和95%在肿块切除术后4年和5年内被发现。寿命表分析显示,未接受肿块切除术和乳腺放疗的患者局部复发率为24%,接受者为6%。104例(95%)乳腺复发累及乳腺实质,其余6例(5%)仅累及皮肤和/或乳头。前者中有11例(10%)为非浸润性。乳腺复发最常见的表现(86%)似乎是在原发癌象限内或附近出现局限性肿块。14%的复发不仅累及同一象限,而且在乳腺内更广泛,还延伸至远处区域。这种类型在病理上的特征是明显的淋巴管内扩散以及出现所谓炎性或隐匿性炎性乳腺癌时累及上方皮肤和/或乳头。仅在皮肤和/或乳头出现的复发在大多数情况下病理特征也是这些部位的淋巴管受累。这两种乳腺复发形式似乎反映了高度侵袭性浸润性乳腺癌的局部生长。原发癌与复发癌的组织学类型和分级的一致性意味着这些事件代表了被忽视肿瘤的生长,这是由于一些乳腺癌具有极端多灶性(而非多中心性)以及/或在评估肿块切除标本的切除线时存在不足而导致的肿块切除的一个缺陷。确定了关于后者的误差来源,并给出了检查此类标本以及评估切缘的指南。尽管在接受全乳切除术的患者中有10%存在多中心非浸润性癌,但肿块切除术后观察到的局部乳腺复发发生在与原发癌相同或附近象限,这使一些乳腺癌中存在的多中心癌灶的生物学和临床意义最小化。在所有接受肿块切除术的患者中,发现肿瘤大小大于或等于2.0 cm、组织学和核分级高或有淋巴管内扩散与局部乳腺复发有统计学显著关联。与1型和4型管状癌及瘢痕癌呈相反关系。(摘要截短于400字)